Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

SoftBank Vision Fund 2 has led a round that took the Salesforce Ventures-backed online classroom tool provider's overall funding to more than $160m.

Carbon-neutral blockchain technology developer Core Scientific raised $54m from Celsius while autoimmune disease therapy developer Topas Therapeutics took a BIVF-backed round past $47m.

TU Munich spinout Isar Aerospace has added $75m to its series B round, bringing the round’s total to nearly $166m and its overall financing to more than $183m.

UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.

Topas Therapeutics has almost doubled its series B round to $48m thanks to an extension backed by all of its shareholders.

Cornell-linked dog DNA test developer Embark Veterinary raised the capital in a round led by SoftBank Vision Fund 2 at a $700m post-money valuation.

Imec.xpand has returned to back a series B round for sleep diagnostic developer Onera Health, spun out of Imec.

Denso took part in a $71m series D round for artificial intelligence technology provider Blaize while inflammatory disease drug developer Aristea closed a $63m Novo and Arena-backed round.

M12 returned to reinvest in the quantum computer developer at a valuation topping $3bn, boosting its overall funding to $665m.